Tian Chi, PhD, MD
About
Appointments
Departments & Organizations
- Rheumatic Diseases Research Core
Education & Training
- PhD
- University of California at Los Angeles (1996)
- MD
- Fudan University Medical School (1987)
Research
Overview
Chromatin dynamics and epigenetic control in the immune system
- Chromatin structure dictates whether a DNA template is accessible to nuclear proteins, and is thus a focal point of gene regulation by signaling pathways. External signals often mobilize "chromatin remodeling complexes (CRC)" and histone modifying enzymes to reversibly reconfigure chromatin, but the altered chromatin states can sometimes be maintained and propagated to daughter cells after the cessation of the signaling event. This latter effect enables transient signals to heritably or "epigenetically" modify gene function without altering DNA sequences, thus providing a molecular basis for cellular memory and lineage differentiation. On the other hand, misdirected epigenetic controls are now recognized to underlie many human diseases. For example, during cancer development, tumor suppressor genes often become inactivated by "epimutations" characterized by aberrant chromatin rather than by classic DNA mutations. Epimutations also explain phenotypic differences between genetically identical twins, between cloned and original animals, and explain the high incidents of birth defects in "test tube babies". Epimutations that occur in the germline can be transmitted across generations, which has been inferred from epidemiological studies of human diseases and directly demonstrated in animal models. Epigenetics has thus emerged as a new frontier in biology, with far-reaching implications. Our long-term goals are to reveal fundamental principles in chromatin biology and epigenetics, and to define how such principles underpin the development and function of the immune system. Below are some of the problems we are tackling:
- How do external signals mobilize CRC? The current dogma is that signaling pathways impinge on CRC indirectly, by controlling transcription factors which then recruit CRC to target genes via physical interactions. Our recent data indicate that the Swi/Snf-like BAF complex, the prototypical mammalian CRC, is subject to a novel mode of regulation. Specifically, Toll-like receptor (TLR) signaling in macrophages is found to activate the ubiquitous signaling molecule calmodulin (CaM), which then directly binds the BAF complex and stimulates BAF-dependent remodeling and expression of target genes essential for the innate immune response. Given that both CaM and BAF complex are ubiquitously expressed, this novel pathway, connecting cell surface receptors to chromatin, should operate in diverse tissues beyond macrophages and thus be of general importance. We have also developed cell permeable peptides that can effectively disrupt CaM-BAF interaction and block the innate immune response in animal models. These inhibitors provide a powerful means for dissecting and manipulating this novel signaling pathway, with important implications in basic and clinical research.
- Novel functions of the BAF complex. Although called "CRC", the BAF complex, like other CRC, carries multiple subunits totally dispensable for remodeling in vitro. Our hypothesis is that the BAF complex has novel functions in gene regulation unrelated to remodeling. To test this, we have developed a general strategy to engineer tissue-specific point mutations in mice. Our data confirm our hypothesis. So far, we have found that the complex uses ATPase-independent activities to stimulate CD4 expression and promote the survival of regulatory T cells. We are studying the molecular basis of such mysterious functions.
- How do transient signals trigger heritable changes in gene function? The signals are thought to imprint on histones certain posttranslational modifications or "epigenetic tags" which are subsequently maintained and transmitted to daughter cells independently of the initial signals. However, the identity of the tags and the mechanisms of their self-perpetuation are poorly understood. We have generated an animal model where transient exposure of mice to a drug (doxycycline) triggers irreversible changes in the expression pattern of a target gene that can be transmitted to future generation. We have thus established the first animal model for transgenerational inheritance of a well-defined gene. Preliminary experiments already reveal an unexpected mechanism underlying such a mode of inheritance.
- Roles of BAF complex in T cell development
- Mechanisms of epigenetic memory and transgenerational inheritance
Medical Research Interests
Chromatin; Epigenesis, Genetic; Epigenetic Repression; Gene Expression; Immune System Phenomena; Immunity
Research at a Glance
Yale Co-Authors
Frequent collaborators of Tian Chi's published research.
Publications Timeline
A big-picture view of Tian Chi's research output by year.
Research Interests
Research topics Tian Chi is interested in exploring.
Paula Preston-Hurlburt
Haifan Lin, PhD
M. Elizabeth Deerhake, MD, PhD
Timothy Nottoli, PhD
22Publications
984Citations
Chromatin
Epigenesis, Genetic
Publications
2024
CasRx-based Wnt activation promotes alveolar regeneration while ameliorating pulmonary fibrosis in a mouse model of lung injury
Shen S, Wang P, Wu P, Huang P, Chi T, Xu W, Xi Y. CasRx-based Wnt activation promotes alveolar regeneration while ameliorating pulmonary fibrosis in a mouse model of lung injury. Molecular Therapy 2024 PMID: 39245939, DOI: 10.1016/j.ymthe.2024.09.008.Peer-Reviewed Original ResearchAltmetricConceptsWnt/b-catenin signalingStem cell activityLung epitheliumAlveolar regenerationPulmonary fibrosisLung fibrosisWnt signalingCell activationMouse models of lung injuryModel of lung injuryWnt activityAlveolar type II cell proliferationBleomycin-induced injuryAmeliorated pulmonary fibrosisActivation of Wnt signalingType II cell proliferationInhibit lung fibrosisRegenerative medicineAnti-fibrotic effectsTreating pulmonary fibrosisActivated Wnt signalingLung injuryMouse modelFibrosisWnt/b-cateninExpanding RNA editing toolkit using an IDR-based strategy
Di M, Lv J, Jing Z, Yang Y, Yan K, Wu J, Ge J, Rauch S, Dickinson B, Chi T. Expanding RNA editing toolkit using an IDR-based strategy. Molecular Therapy - Nucleic Acids 2024, 35: 102190. PMID: 38721279, PMCID: PMC11077028, DOI: 10.1016/j.omtn.2024.102190.Peer-Reviewed Original ResearchAltmetric
2022
iMAPping the Perturb-Atlas
Sun Y, Lin W, Kaundal R, Chi T. iMAPping the Perturb-Atlas. Life Medicine 2022, 2: lnac057. DOI: 10.1093/lifemedi/lnac057.Peer-Reviewed Original ResearchAltmetricPPARγ phase separates with RXRα at PPREs to regulate target gene expression
Li Z, Luo L, Yu W, Li P, Ou D, Liu J, Ma H, Sun Q, Liang A, Huang C, Chi T, Huang X, Zhang Y. PPARγ phase separates with RXRα at PPREs to regulate target gene expression. Cell Discovery 2022, 8: 37. PMID: 35473936, PMCID: PMC9043196, DOI: 10.1038/s41421-022-00388-0.Peer-Reviewed Original ResearchCitationsConceptsPPAR response elementNuclear condensatesTranscriptional activationPPRE siteZinc finger motifsDNA binding domainsKey transcription activatorSpecific transcriptional activationTarget gene expressionPPARγ/RXRαRetinoid X receptor αPPARγ target genesFinger motifPhase-separated dropletsTranscription activatorTranscriptional responseObligate heterodimersTarget genesX receptor αBinding domainsGene expressionResponse elementPeroxisome proliferator-activated receptorNovel mechanismProliferator-activated receptor
2021
EasyCatch, a convenient, sensitive and specific CRISPR detection system for cancer gene mutations
Liu Y, Chen Y, Dang L, Liu Y, Huang S, Wu S, Ma P, Jiang H, Li Y, Pan Y, Wei Y, Ma X, Liu M, Ji Q, Chi T, Huang X, Wang X, Zhou F. EasyCatch, a convenient, sensitive and specific CRISPR detection system for cancer gene mutations. Molecular Cancer 2021, 20: 157. PMID: 34856977, PMCID: PMC8638196, DOI: 10.1186/s12943-021-01456-x.Peer-Reviewed Original ResearchCitationsAltmetric
2017
Chapter 15 Mouse Models of Epigenetic Inheritance: Classification, Mechanisms, and Experimental Strategies
Mao S, Li Y, Liu B, Chi T. Chapter 15 Mouse Models of Epigenetic Inheritance: Classification, Mechanisms, and Experimental Strategies. 2017, 231-243. DOI: 10.1016/b978-0-12-805388-1.00015-8.Peer-Reviewed Original ResearchConceptsEpigenetic inheritanceChromatin modificationsHeritable chromatin modificationsHeritable epigenetic statesSimple reporter geneEpigenetic stateExperimental strategiesEpigenetic mechanismsMolecular basisReporter geneMouse modelInheritanceInheritance modelEnvironmental factorsCompelling evidenceMechanistic studiesEmbryogenesisExtensive contributionsGenesTraitsMechanismMechanistic problemsModificationInducerOffspring
2014
Chapter 8 Towards the Molecular Mechanisms of Transgenerational Epigenetic Inheritance Insights from Transgenic Mice
Kaundal R, Yang Y, Nottoli T, Chi T. Chapter 8 Towards the Molecular Mechanisms of Transgenerational Epigenetic Inheritance Insights from Transgenic Mice. 2014, 75-85. DOI: 10.1016/b978-0-12-405944-3.00008-8.Peer-Reviewed Original ResearchCitationsConceptsTransgenerational epigenetic inheritanceChromatin marksChromatin modificationsEpigenetic inheritanceGlobal epigenetic reprogrammingTraditional transgenic miceCopy numberGene-targeting methodsSite-specific integrationMitotic inheritanceHeritable perturbationsEpigenetic reprogrammingTransgenerational inheritanceTractable systemEpigenetic modificationsUnderlying genesEpigenetic perturbationsCpG methylationTransgenic miceGenetic strategiesReporter geneCOL1A1 locusMolecular mechanismsSubsequent embryogenesisGermline transmission
2013
Inducible mouse models illuminate parameters influencing epigenetic inheritance
Wan M, Gu H, Wang J, Huang H, Zhao J, Kaundal RK, Yu M, Kushwaha R, Chaiyachati BH, Deerhake E, Chi T. Inducible mouse models illuminate parameters influencing epigenetic inheritance. Development 2013, 140: 843-852. PMID: 23325759, PMCID: PMC3557779, DOI: 10.1242/dev.088229.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsConceptsTransgenerational inheritanceEpigenetic perturbationsModification patternsChromatin modification patternsRepressive chromatin modificationsAberrant epigenetic modificationsTarget gene sequenceMitotic inheritanceChromatin modificationsEpigenetic inheritanceEpigenetic stateMetastable epiallelesEpigenetic modificationsTranscription factorsGene sequencesDNA sequencesEpigenetic programmingTarget genesCOL1A1 locusFetal epigenomeExtraordinary malleabilityPleiotropic effectsInducible mouse modelEpigenomeTransient manipulationA General Approach for Controlling Transcription and Probing Epigenetic Mechanisms: Application to the Cd4 Locus
Wan M, Kaundal R, Huang H, Zhao J, Yang X, Chaiyachati BH, Li S, Chi T. A General Approach for Controlling Transcription and Probing Epigenetic Mechanisms: Application to the Cd4 Locus. The Journal Of Immunology 2013, 190: 737-747. PMID: 23293358, PMCID: PMC3744393, DOI: 10.4049/jimmunol.1201278.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsBRG1‐mediated immune tolerance: facilitation of Treg activation and partial independence of chromatin remodelling
Chaiyachati BH, Jani A, Wan Y, Huang H, Flavell R, Chi T. BRG1‐mediated immune tolerance: facilitation of Treg activation and partial independence of chromatin remodelling. The EMBO Journal 2013, 32: 395-408. PMID: 23321680, PMCID: PMC3567501, DOI: 10.1038/emboj.2012.350.Peer-Reviewed Original ResearchCitationsMeSH Keywords and ConceptsConceptsTreg activationRegulatory T cellsSeverity of inflammationChemokine receptor genesT-cell lineageΑβ T cell lineagesCD4 cellsSuppress autoimmunityProinflammatory roleImmune toleranceFatal inflammationT cellsInflammatory cuesTregsInflammationBrg1 deletionReceptor geneChromatin-remodelling factor BRG1Activation levelsActivationCell lineagesTarget genesATPase activityPoint mutationsCells
Get In Touch
Contacts
Email
Academic Office Number
Locations
The Anlyan Center
Academic Office
300 Cedar Street, Ste Suite 555A
New Haven, CT 06519